T
| HTA ID | Drug | Brand | Indication | Assessment status | Date | |
| 22011 | Trifluridine/tipiracil | Lonsurf® | As monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease. | Rapid Review Complete | 15th March 2022 |  |
| 22058 | Tucatinib | Tukysa® | In combination with trastuzumab and capecitabine for the treatment of adult patients with HER2-positive locally advanced or metastatic breast cancer wo have received at least two prior anti-HER2 treatment regimens. | Awaiting response from Applicant | 10th April 2025 | |
